Sensitization of Glioblastoma Cells to Irradiation by Modulating the Glucose Metabolism.

W. Christopher Newman,Edward A. Monaco

DOI: https://doi.org/10.1227/01.neu.0000471838.05005.51

IF: 5.315

2015-10-01

Neurosurgery

Abstract:tumor proliferation through the phosphoinositide 3-kinase-mammalian target of rapamycin (mTOR) pathway. Interestingly, the cultured HGG lines demonstrated increased expression of NLGN-3 when exposed to conditioned medium, implicating a feed-forward mechanism of expression. This further explains the robust proliferation seen in the experimental setting and allows greater rationale of targeting this pathway therapeutically. The clinical implications of this discovery were made clear with a query of The Cancer Genome Atlas.Although somaticmutations ofNLGN3 were infrequent in pediatric and adult brain tumors, mRNA expression was found to be inversely correlated with overall patient survival in 429 cases, with a hazard ratio for death with high vs low expression of 1.31 (95% confidence interval, 1.051.63). The specificity of the aforementioned results was strengthened by examination of the role of Nlgn-2, which did not demonstrate increased proliferation or survival differences. The implication of these findings, that the inherent physiological function of the host organ could be taken advantage of by a primary tumor, has far-reaching impact. Neuronal activity can induce tumor proliferation via the mTOR pathway, whereas the mTOR pathway has been implicated in the pathogenesis of a number of human epilepsies. Thus, brain activity may promote tumor growth, which in turn may induce pathological brain activity in a vicious cycle. However, this discovery also may provide a targetable checkpoint in glioma proliferation and pathogenesis. It adds a missing element to the glioma microenvironmental landscape and allows a new avenue for exploring diagnostic and therapeutic possibilities. Although a sobering finding regarding this devastating diagnosis, the neuronal contribution to the pathogenesis of HGG is critical to characterize and dissect so that it can be translated to the clinical treatment of glioma patients.